v.28 – Q4 2023

Market Executive Summary Drug Traceability requirements are currently on hold in the Philippines per FDA circular 2016-011 on 25 July 2016. Voluntary compliance is encouraged.
Key Dates
  • July 2016: Drug Traceability requirements placed on hold
  • June 2015: Global Establishment Id Number and Global Product Identification # (GPIN) guidance released, 14-digit GPIN reflected on product labeling + lot number & expiry date; Applications require both GPIN and Global Establishment ID by December 31, 2015

<-- Return to Countries